accountbig of a drug as Lipitor, its loss is going to hurt Lilly more than Lipitor will hurt Pfizer (NYSE: PFE Investors are valuing Lilly at 9.6 times 2012 projected earnings. Whether that's cheap depends on whether Lilly can exceed analysts' expectations next...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to See You on the Other Side of the Cliff
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account